Yellow fever risk assessment in the Central African Republic.
Yellow fever still causes high burden in several areas of sub-Saharan Africa and Latin America. There are few well-designed epidemiological studies and limited data about yellow fever in Africa. Staples et al., in a recently published paper in Transactions of the Royal Society of Tropical Medicine & Hygiene, performed a nationwide study in the Central African Republic (CAR) assessing infection risk and the operational impact of preventive measures. The rapid assessment of human, non-human and mosquito data call attention to the potential risk of future yellow fever outbreaks in the CAR and elsewhere. The study reinforces the need for intensified applied and operational research to address problems and human capacity needs in the realm of neglected tropical diseases in the post-2015 agenda.
Department of Community Health, School of Medicine, Federal University of Ceará, Brazil novaes@ufc.br.
Alberto Novaes
AN
Ramos Junior
Department of Community Health, School of Medicine, Federal University of Ceará, Brazil Anton Breinl Centre for Public Health and Tropical Medicine, School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Townsville, Australia.
Jorg
J
Heukelbach
D000818:Animals; D002488:Central African Republic; D004196:Disease Outbreaks / Q000517:prevention & control*; D004781:Environmental Exposure; D006297:Health Services Accessibility / Q000458:organization & administration*; D006801:Humans; D007303:Insect Vectors; D032541:Mass Vaccination / Q000458:organization & administration*; D011159:Population Surveillance; D011315:Preventive Medicine; D011323:Primates; D018570:Risk Assessment; D015004:Yellow Fever / Q000453:epidemiology* / Q000517:prevention & control*
Central African Republic; Epidemiology; Yellow fever